首页> 外国专利> METHOD FOR PREDICTION OF LETHAL OUTCOME IN CLINICAL COURSE OF COINFECTION OF HIV AND TUBERCULOSIS, ACCOMPANIED BY MULTIPLE DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS

METHOD FOR PREDICTION OF LETHAL OUTCOME IN CLINICAL COURSE OF COINFECTION OF HIV AND TUBERCULOSIS, ACCOMPANIED BY MULTIPLE DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS

机译:预测艾滋病毒和结核合并感染临床过程中的结局结果的方法,并伴有多种抗药性结核分枝杆菌

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to infectious diseases, phthisiology and therapy. Disclosed is a method for prediction of lethal outcome in clinical course of HIV-tuberculosis coinfection, wherein in the patients with the detected multiple drug-resistant Mycobacterium tuberculosis and the known amount of CD4-lymphocytes, venous blood samples are taken, blood plasma isolation and ELISA test to determine concentration of nonspecific total immunoglobulins IgE in IU/ml, IgM in mg/ml, IgA in mg/ml and secretory IgA in mg/l in blood plasma, calculating prediction coefficient of lethal outcome (CP) equal to ratio of product of their concentrations to CD4-lymphocyte count in 1 mcl of blood and if this coefficient exceeds value 200, lethal outcome is predicted with 56.7-fold relative risk.;EFFECT: invention enables predicting the unfavorable outcome of the disease with a high probability and correcting the therapeutic approach of the given cohort of patients, which contributes to reducing mortality.;1 cl, 3 tbl, 3 ex
机译:技术领域:发明:药物是指传染性疾病,生理学和治疗学。公开了一种预测HIV-结核合并感染临床过程中致死结果的方法,其中在检测到多种耐药结核分枝杆菌且已知CD4淋巴细胞量的患者中,抽取静脉血样本,血浆分离和ELISA试验确定血浆中IU / ml的非特异性总免疫球蛋白IgE的浓度,mg / ml的IgM,mg / ml的IgA和mg / l的分泌性IgA的浓度,计算致死结果(CP)的比率等于浓度与1 mcl血液中CD4淋巴细胞计数的乘积,如果该系数超过200,则可以预测致死结果,其相对危险度为56.7倍。效果:本发明能够以高概率预测疾病的不利结果,并且纠正给定患者队列的治疗方法,这有助于降低死亡率。; 1 cl,3 tbl,3 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号